跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zymax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zymax
Approved
STANDARD
Zymax
Biopharma Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e6872ec6d48bac37
Company
Biopharma Laboratories Limited
Type
Standard
Approval Details
Approval Id
e6872ec6d48bac37
Drug Approval Philippines Name
Zymax
Product Name
Zymax
Registration Number
DRP-5134
Brand Name
Zymax
Generic Name
Azithromycin (as Dihydrate)
Dosage Form
Powder For Suspension
Dosage Strength
200mg/5mL
Manufacturer
Biopharma Laboratories Limited
Importer
JF Draf Pharmaceuticals Corporation
Issuance Date
29 February 2024
Expiry Date
13 February 2029
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e6872ec6d48bac37
Type
Standard
Back to Philippines FDA Approvals